|
|||||
|
|
Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data |
|
| Authors: | Christopher M. Black Eric Yu Eilish McCann Sumesh Kachroo |
| Affiliation: | 1. Merck & Co, Inc., Kenilworth, United States of America;2. IMS Health Ltd, London, United Kingdom;3. Merck Sharp & Dohme Ltd, Hoddesdon, United Kingdom;Corvinus University of Budapest, HUNGARY |
| Abstract: | |
| Keywords: | |